SQZ-TAC-AAV

N/A

Report date: 2024/07/04 18:02:59

Base Information

Drug NameSQZ-TAC-AAV
Drug Alias NameSQZ-TAC-AAVSQZ AACs
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesAutoimmune Diseases of the Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSQZ Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesSQZ Biotech IncSqz Biotechnologies Company
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesAutoimmune Diseases of the Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A